Clinical Cardiology Alert – January 1, 2009
January 1, 2009
View Issues
-
The Amazing Journey to JUPITER
JUPITER, a trial first presented november 9, 2008, at the american Heart Association meeting in New Orleans, was clearly "the bell of the ball," with multiple television, newspaper, and medical journal reports. -
Combination Therapy for Hypertension
In order to achieve new aggressive blood pressure goals in hypertensive patients, drug combinations are often used. But which combinations are superior for preventing cardiovascular events? -
Coronary CT Angiography: Are We There Yet?
Invasive coronary angiography (ICA) is the gold standard for assessment of epicardial coronary artery disease. There is much interest in non-invasive alternatives to ICA to assess coronary arteries in order to eliminate the complications associated with arterial access and catheter manipulation during ICA. -
Pulmonary Vein Isolation vs AV Node Ablation Plus Pacing
Khan et al report a multicenter trial comparing pulmonary vein isolation vs AV junctional ablation with biventricular pacing in patients with atrial fibrillation and heart failure. -
Identifying Candidates for ICD Therapy
The Microvolt t-wave Alternans Testing for risk Stratification of Post-Myocardial Infarction Patients (MASTER) trial tested the hypothesis that microvolt T-wave alternans (MTWA) testing could successfully predict arrhythmia occurrence in patients receiving an ICD for primary prevention of sudden cardiac death. -
Clinical Briefs in Primary Care Supplement
-
Pharmacology Watch
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.